No Data
Insiders At Regeneron Pharmaceuticals Sold US$26m In Stock, Alluding To Potential Weakness
Form 144 | Regeneron Pharmaceuticals(REGN.US) Officer Proposes to Sell 1.19 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Regeneron Pharmaceuticals(REGN.US)$ Officer MARION E MCCOURT intends to sell 1,137 shares of its common stock on Jul 1, with a total market value of approximately $1.19
What's Going On With Regeneron Pharmaceuticals Stock On Friday?
On Friday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending conditi
CHMP Recommends Regeneron Lymphoma Antibody Drug for Conditional Approval
Regeneron's Odronextamab Receives Opinion From EMA for Lymphoma Treatment
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommendi
Express News | Odronextamab Recommended for EU Approval by the Chmp to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
RDK79 : I recognized one word in that lead sentence:)))
But it sounds like good news!!!